We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Transient receptor potential cation channel subfamily M member 4 (TRPM4) antibody
Transient receptor potential cation channel subfamily M member 4
Calcium-activated non-selective cation channel 1
Long transient receptor potential channel 4, LTrpC-4, LTrpC4
Melastatin-4
Gene name: Trpm4, LTRPC4, TRPM4B, AW047689, 1110030C19Rik
Calcium-activated non-selective cation channel 1
Long transient receptor potential channel 4, LTrpC-4, LTrpC4
Melastatin-4
Gene name: Trpm4, LTRPC4, TRPM4B, AW047689, 1110030C19Rik
As low as
$306.10
In stock
Ref
00014675
Calcium-activated non selective (CAN) cation channel that mediates membrane depolarization. While it is activated by increase in intracellular Ca2+, it is impermeable to it. Mediates transport of monovalent cations (Na+ > K+ > Cs+ > Li+), leading to depolarize the membrane. It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, endocrine pancreas cells, kidney epithelial cells, cochlea hair cells etc. Participates in T-cell activation by modulating Ca2+ oscillations after T lymphocyte activation, which is required for NFAT-dependent IL2 production. Involved in myogenic constriction of cerebral arteries. Controls insulin secretion in pancreatic beta-cells. May also be involved in pacemaking or could cause irregular electrical activity under conditions of Ca2+ overload. Affects T-helper 1 (Th1) and T-helper 2 (Th2) cell motility and cytokine production through differential regulation of calcium signaling and NFATC1 localization. Enhances cell proliferation through up-regulation of the beta-catenin signaling pathway.
Defects in TRPM4 are the cause of progressive familial heart block type 1B (PFHB1B) [MIM:604559]. It is a cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrioventricular block causing syncope and sudden death.
Defects in TRPM4 are the cause of progressive familial heart block type 1B (PFHB1B) [MIM:604559]. It is a cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrioventricular block causing syncope and sudden death.
ID Covalab | pab0563 |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Raised in | Rabbit |
Immunogen | Synthetic peptide derived from internal domain of the mouse TRPM4 protein. |
Activity cross reaction | Reacts with mouse and rat Trpm4 protein. |
Species | Ms, Rat |
Labelling | None |
Form | Antiserum |
Preservative | None |
Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
Target | Transient receptor potential cation channel subfamily M member 4 |
Uniprot ID | Q7TN37 |
Gene ID | 68667 |
Applications | ELISA, ICC, WB |
Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : ICC (1:100 - 1:500) WB (1:500 - 1:5000) |
Write Your Own Review